Cleared Traditional

K935057 - FACTOR VIII DEFICIENT PLASMA

K935057 is an FDA 510(k) clearance for FACTOR VIII DEFICIENT PLASMA, manufactured by Sigma Diagnostics, Inc.. The device is a Class 2 Hematology device with product code GJT cleared through the Traditional 510(k) pathway after a 145-day FDA review.

K935057 · Sigma Diagnostics, Inc. · Hematology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 1994
Decision
145d
Days
Class 2
Risk

K935057 is an FDA 510(k) clearance for the FACTOR VIII DEFICIENT PLASMA. Classified as Plasma, Coagulation Factor Deficient (product code GJT), Class II - Special Controls.

Submitted by Sigma Diagnostics, Inc. (St. Louis, US). The FDA issued a Cleared decision on March 15, 1994 after a review of 145 days - within the typical 510(k) review window.

This device falls under the Hematology FDA review panel, regulated under 21 CFR 864.7290 - the FDA hematology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Hematology review framework, consistent with the majority of Class II 510(k) submissions.

View all Sigma Diagnostics, Inc. devices

FDA 510(k) Submission Details - K935057

510(k) Number K935057 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 21, 1993
Decision Date March 15, 1994
Days to Decision 145 days
Submission Type Traditional
Review Panel Hematology (HE)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
32d slower than avg
Panel avg: 113d · This submission: 145d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GJT Device Classification - Class 2, Special Controls

Product Code GJT Plasma, Coagulation Factor Deficient
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 864.7290
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Hematology devices follow this clearance model.

Regulatory Peers - GJT Plasma, Coagulation Factor Deficient

All 74
Devices cleared under the same product code (GJT) and FDA review panel - the closest regulatory comparables to K935057.
HEMOLAB COFAC IX
K942050 · Biomerieux Vitek, Inc. · May 1995
BIOMERIEUX HEMOLAB COFAC VII
K935850 · Biomerieux Vitek, Inc. · Jan 1995
BIOMERIEUX HEMOLAB COFAC X
K935851 · Biomerieux Vitek, Inc. · Jan 1995
FACTOR X DEFICIENT PLASMA
K935054 · Sigma Diagnostics, Inc. · Mar 1994
FACTOR VII DEFICIENT PLASMA
K935056 · Sigma Diagnostics, Inc. · Mar 1994
FACTOR
K935058 · Sigma Diagnostics, Inc. · Mar 1994